Your browser doesn't support javascript.
loading
Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors.
Whitehead, Lewis; Dobler, Markus R; Radetich, Branko; Zhu, Yanyi; Atadja, Peter W; Claiborne, Tavina; Grob, Jonathan E; McRiner, Andrew; Pancost, Margaret R; Patnaik, Anup; Shao, Wenlin; Shultz, Michael; Tichkule, Ritesh; Tommasi, Ruben A; Vash, Brian; Wang, Ping; Stams, Travis.
Afiliação
  • Whitehead L; Novartis Institutes for Biomedical Research, 100 Technology Square & 250 Massachusetts Avenue, Cambridge, MA 02139, USA. lewis.whitehead@novartis.com
Bioorg Med Chem ; 19(15): 4626-34, 2011 Aug 01.
Article em En | MEDLINE | ID: mdl-21723733
ABSTRACT
Herein we report the discovery of a family of novel yet simple, amino-acid derived class I HDAC inhibitors that demonstrate isoform selectivity via access to the internal acetate release channel. Isoform selectivity criteria is discussed on the basis of X-ray crystallography and molecular modeling of these novel inhibitors bound to HDAC8, potentially revealing insights into the mechanism of enzymatic function through novel structural features revealed at the atomic level.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Acético / Inibidores de Histona Desacetilases / Aminoácidos / Histona Desacetilases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Acético / Inibidores de Histona Desacetilases / Aminoácidos / Histona Desacetilases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2011 Tipo de documento: Article